Skip to main content

Dexcom Inc(DXCM-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low60.34
Day High62.90
Open:62.67
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
StockStory
1 Cash-Producing Stock to Target This Week and 2 Facing Challenges
ERII
Motley Fool
Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins
Zacks Investment Research
ISRG Stock Up as Q1 Earnings & Sales Beat Estimates on Procedure Growth
ISRG Stock Up as Q1 Earnings & Sales Beat Estimates on Procedure Growth
Tipranks
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Ionis Pharmaceuticals (IONS) and Dexcom (DXCM)
Motley Fool
Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom
Motley Fool
2 Healthcare Stocks That Could Outperform the Market Over the Next Decade
StockStory
3 Reasons Investors Love DexCom (DXCM)
DXCM
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Dexcom (DXCM) and Pro Medicus Limited (OtherPMCUF)
Tipranks
Mizuho Securities Remains a Buy on Dexcom (DXCM)
Tipranks
BTIG Keeps Their Buy Rating on Dexcom (DXCM)
Tipranks
Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Solventum Corporation (SOLV) and Shattuck Labs (STTK)
StockStory
Q4 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks
DXCM
Motley Fool
DexCom (DXCM) Q2 2025 Earnings Call Transcript
Tipranks
Dexcom (DXCM) Gets a Buy from Citi
Tipranks
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX) and Dexcom (DXCM)
StockStory
2 Growth Stocks with All-Star Potential and 1 That Underwhelm
NX
StockStory
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know
ALGN
StockStory
2 of Wall Street’s Favorite Stocks with Solid Fundamentals and 1 Facing Headwinds
VEEV
StockStory
2 Healthcare Stocks to Target This Week and 1 That Underwhelm
DXCM
StockStory
Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know
FTRE
Zacks Investment Research
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now
Motley Fool
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment
Motley Fool
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement
Motley Fool
This Internet Infrastructure Stock Plunged 72% in a Year, so Why Did an Investor Buy Up $12 Million?
Motley Fool
Sotera Health Shares Rise 18% in a Year. Here's What a $37 Million Stake Trim Signals
Motley Fool
2 Growth Stocks to Hold for the Next Decade
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Dexcom (DXCM), Medline (MDLN)
StockStory
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know
TECH
Tipranks
Dexcom Executive Chairman Kevin Sayer Returns From Leave
Tipranks
Jefferies Sticks to Their Buy Rating for Dexcom (DXCM)
StockStory
1 Nasdaq 100 Stock with Impressive Fundamentals and 2 We Avoid
CMCSA
Tipranks
Dexcom Adds Google Executive Rick Osterloh to Board

Profile

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.